Avai Bio (AVAI) Other Operating Expenses (2018 - 2026)

Avai Bio has disclosed Other Operating Expenses across 9 years of filings, most recently posting $243303.0 for Q2 2026.

• In Q2 2026, Other Operating Expenses fell 11.11% year-over-year to $243303.0; the TTM figure through Jun 2026 stood at $573527.0 (down 26.36% YoY), while the FY2026 annual figure was $671426.0, down 12.74% from the prior year.
• Other Operating Expenses came in at $243303.0 for Q2 2026 at Avai Bio, up from -$95271.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $603084.0 in Q1 2024 to a low of -$95271.0 in Q1 2026.
• Average Other Operating Expenses over 5 years is $136392.5, with a median of $105840.0 recorded in 2025.
• Year-over-year, Other Operating Expenses soared 1668.49% in 2024 and sank 169.77% in 2026.
• Over 5 years, Other Operating Expenses stood at $10783.0 in 2022, then jumped by 159.36% to $27967.0 in 2023, then soared by 503.56% to $168797.0 in 2024, then soared by 89.37% to $319655.0 in 2025, then dropped by 23.89% to $243303.0 in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $243303.0 in Q2 2026, -$95271.0 in Q1 2026, and $319655.0 in Q4 2025.